Injury Traumatic, Survivorship, Trauma Injury
Conditions
Keywords
Social determinants of health, Community-engaged research, Unmet needs
Brief summary
The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is: • Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors? Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.
Interventions
OTHERHuman-Centered Injury Thrivorship Pathway
Enrollment in the human-centered injury thrivorship pathway.
Sponsors
University of California, San Francisco
National Center for Advancing Translational Sciences (NCATS)
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital * Admitted to the hospital ≥ 24 hours * Discharged from the hospital alive * San Francisco resident or unhoused in San Francisco * Capacity for informed consent
Exclusion criteria
* Patient \< 18 years old * Deceased during index hospitalization * Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility | 8-12 weeks post-pathway enrollment | Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting." |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Participant pathway resource utilization - type | 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year | Participant engagement with applicable pathway resources will be tracked by type of resource(s) accessed |
| Participant pathway resource utilization - frequency | 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year | Participant engagement with applicable pathway resources will be tracked by frequency of use of the resource(s) |
| Participant pathway resource utilization - duration | 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year | Participant engagement with applicable pathway resources will be tracked by duration of use of the resource(s) |
| Participant pathway resource utilization - % utilized | 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year | Participant engagement with applicable pathway resources will be tracked by overall % of resources utilized out of resource(s) offered |
Countries
United States
Contacts
CONTACTMarissa A Boeck, MD, MPH
PRINCIPAL_INVESTIGATORMarissa A Boeck, MD, MPH
University of California, San Francisco
Outcome results
None listed